DeepMind's health subsidiary, maker of an app called Streams that helps with diagnosing specific conditions, is moving under the newly-formed Google Health unit
Context & Ripple Effects
DeepMind has been building toward this for two years: it formed a dedicated health unit in early 2016 to turn research into medical software, then signed a five-year data sharing deal with NHS Royal Free to deploy the Streams clinician app across three London hospitals. Moving that subsidiary under the newly created Google Health unit — led by former Geisinger CEO David Feinberg, per sources — formally separates DeepMind's clinical product line from the research lab that built it.
The reorganization also foreshadows what came after: by mid-2021 Google was downsizing the health team and shifting sensor and records work to Fitbit, before dismantling the division entirely and scattering its units. This 2018 move is the hinge where an ambitious standalone health moonshot became just another Google product group.
First-order effects
- Streams and its NHS hospital deployments now answer to Google Health's Palo Alto operation under David Feinberg rather than to DeepMind in London, putting clinicians' day-to-day tooling inside Google's product org.
Second-order effects
- NHS partners whose data agreements were struck with DeepMind's research brand now find their counterpart embedded in Google proper, raising the governance stakes for any renewal of those deals.
Third-order effects
- The arc from standalone lab to absorbed product unit to eventual dissolution shows Big Tech health efforts surviving only when attached to shipping products — a structure that leaves hospital customers dependent on corporate reorganizations they don't control.
The trend: Big Tech health divisions are being folded from research-lab moonshots into product-line ownership, with clinical deployments inheriting whatever structure the parent company's next reorganization imposes.